IRBESARTAN (IRBESARTAN) — FDA Approval ANDA211056 (IPCA LABS LTD)
IRBESARTAN (IRBESARTAN) — FDA Approval ANDA211056 (IPCA LABS LTD) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: IRBESARTAN; Active ingredients: IRBESARTAN; Application number: ANDA211056.
| Brand name | IRBESARTAN |
|---|---|
| Active ingredients | IRBESARTAN |
| Application number | ANDA211056 |
| Sponsor | IPCA LABS LTD |
| Dosage form | TABLET |
| Route | ORAL |
| Marketing status | Discontinued |
| Products in application | 3 |
| First approval date | 20240522 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →